Dear Colleagues and Friends,

  First of all I would like to thank you for trusting me as the new President of FARO (2017-2018). FARO was established on November 3rd, 2014 during its preparatory meeting in Yogyakarta, Indonesia. FARO itself is a non-profit and scientific organization which is intended to function as a federation of radiation oncology societies in Asia and aims to foster the role of radiation oncology to improve the basic level of radiotherapy for the benefit of the patients in the region.
  Asia is a major part of the global community which comprises more than 50% of the world population. It is also the most heterogeneous and diverse region. Therefore, Asia has big potential and opportunity to become a very strong region. FARO supports all radiation oncologists especially those in Asia region in their daily practice. We are here to empower the radiation oncologists to serve better treatment for cancer patients. By this far, FARO has 12 participating countries from 12 radiation oncology societies in Asia and I hope it will continue to grow bigger and stronger as time goes by.  
  In order to achieve those goals, FARO needs to work together with organizations inside and outside the region, building bigger and stronger partnerships between radiation oncology societies to achieve our common goals. We are always open to receive your ideas and feedback, particularly about how we can work more effectively together. 
  Let’s walk together towards a better future.

Best regards,
Soehartati Gondhowiardjo, MD, PhD.
President of FARO


Dear Colleagues and Friends,


I am very excited to announce that the Federation of Asian Organizations for Radiation Oncology (FARO) has been founded with great efforts of the delegates from radiation oncology societies of Asian countries. In the 2nd preparatory meeting for foundation of FARO, which was held in Yogyakarta, Indonesia on November 3, 2014, national organizations from 11 countries formally agreed to the foundation of FARO. FARO is established to build a strong union of national radiation oncology societies in Asia and ultimately to improve the healthcare for the patients by cooperation in research, education, and clinical practice of radiation therapy among the member societies.

  FARO will start by cooperation in education and clinical research in radiation oncology to meet the needs of Asian countries. In fact, the status of radiation oncology in Asia varies substantially from countries to countries, and the participating societies need to cooperate with dedication to fill this gap and achieve mutual development. It is my honor to dedicate myself to this effort as the Secretary General of FARO, and I hope to contribute with my experiences of international cooperation with Asian colleagues in IAEA/RCA activities.

  I would like to request to the members of FARO for strong cooperation and support and hope that the activities of FARO will lead to the further improvement of radiation oncology in and beyond Asia in the future.


Takashi Nakano, MD, PhD
Secretary General of FARO


Greetings from President of FARO in 2015 - 2016

Dear Colleagues and Friends


It is great pleasure and honor to announce that the Federation of Asian Organizations for Radiation Oncology (FARO) has been founded on November 3, 2014. FARO is the federation of national radiation oncology societies in Asia, and 11 societies have joined FARO as founding organizations. As the first President of FARO, I would like to express my sincere gratitude for tremendous efforts by the delegates of the 11 organizations and especially to the effort of Prof. Takashi Nakano, the first Secretary General of FARO, who has contributed significantly to its preparation.

The mission of FARO is to provide a platform to promote education & training, scientific exchange, and research in radiation oncology through continuous cooperation and communication among Asian countries for the professionals in the field of radiation oncology and, more importantly, for cancer patients of this region.

While FARO has a great potential to contribute to the development of radiation oncology in Asia, it is still in its initial phase. I sincerely hope that FARO will develop greatly in cooperation with many colleagues and friends not only in Asia and but in all parts of the world.




Masahiro Hiraoka, MD, PhD


The President, FARO in 2015-2016